SCHEMBL3846035

SCHEMBL3846035

O=S(=O)(c1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cc23)s1)N1CCOCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.37
CYP1A2 P05177 5/20 0.37
CYP3A4 P08684 5/20 0.37
ALDH1A1 P00352 4/20 0.37
CYP2D6 P10635 3/20 0.37
HSD17B10 Q99714 2/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
ALOX5AP P20292 5/20 0.37
FEN1 P39748 5/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 2/20 0.35
CLK4 Q9HAZ1 5/20 0.35
TSHR P16473 4/20 0.35
MAPK1 P28482 4/20 0.35
HIF1A Q16665 3/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847208 0.94 L3MBTL1 (0.35) ALDH1A1POLBALOX5APFEN1MEN1
SCHEMBL3848730 0.93 ALOX5AP (0.35) ALDH1A1POLBALOX5APFEN1KIT
SCHEMBL3846511 0.91 ALOX5AP (0.36) CYP2C19CYP1A2CYP3A4ALDH1A1CYP2D6
SCHEMBL3848129 0.87 KIT (0.33) CYP3A4HPGDALOX5APFEN1KIT
SCHEMBL3846935 0.86 KIT (0.34) KITPDPK1
SCHEMBL3854489 0.86 PTGS2 (0.35) CYP2C19CYP1A2CYP3A4CYP2D6HPGD
SCHEMBL3848257 0.85 CYP1A2 (0.36) CYP2C19CYP1A2CYP3A4ALDH1A1CYP2D6
SCHEMBL3846696 0.85 KIT (0.35) CYP2C19CYP1A2CYP3A4CYP2D6HPGD
SCHEMBL3856580 0.85 MAPK1 (0.39) CYP2C19CYP1A2CYP3A4ALDH1A1CYP2D6
SCHEMBL3849955 0.84 KIT (0.36) CYP2C19CYP1A2CYP3A4ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed